Employer Profile: Genentech Inc.

About Genentech Inc.

Genentech Inc., a biotechnology company, engages in the discovery, development, manufacture, and commercialization of biotherapeutics for medical needs. It manufactures and commercializes multiple products for a variety of medical conditions, including cancer, heart attack, allergic asthma, psoriasis, stroke, growth hormone deficiency, and cystic fibrosis in the United States.

The company’s product portfolio comprises Rituxan, an anti-CD20 antibody; Herceptin, an anti-HER2 antibody; Nutropin Depot growth hormone; Nutropin growth hormone; Protropin growth hormone; Nutropin AQ, a liquid formulation growth hormone; TNKase, a thrombolytic agent; Activase, a tissue plasminogen activator; Cathflo Activase; Pulmozyme, an inhalation solution; Xolair, an anti-IgE antibody; Raptiva, an anti-CD11a antibody; and Avastin, a humanized antibody. It also licenses various additional products to other companies. Genentech’s products under development cover various medical conditions, including cancer, respiratory disorders, cardiovascular diseases, endocrine disorders, and inflammatory and immune problems.

In addition, the company, jointly with Rinat Neuroscience Corp., develops RI 624, a humanized monoclonal antibody that blocks nerve growth factor. Genentech has collaboration agreements with Array Biopharma, Inc. and Curis, Inc. for the discovery of targeted small-molecule drugs for the treatment of cancer; with Accelerate Brain Cancer Cure relating to Avastin in patients with glioblastoma multiforme, a form of brain cancer; with PIramed, Ltd. to develop anti-cancer drugs; and with Lexicon Genetics, Inc. to discover and develop biotherapeutic drugs.

The company’s products are sold primarily to wholesalers, specialty distributors, or directly to hospital pharmacies. Genentech was founded by Robert A. Swanson and Herbert W. Boyer in 1975. The company is headquartered in South San Francisco, California.

All contents © Copyright 2005 Sales Careers Online All rights reserved.